feed-icon-14x14News

NCATS Online Course in Translational Science in the COVID-19 Pandemic Jan 31–March 18


Visit the Course Website Course Dates: January 31 to March 18 Enhance your translational science skills this spring with a seven-week online course, MEDI 502: Translational Science in the COVID-19 Pandemic — Accelerating and Enhancing Our Response Across Preclinical, Clinical and Population Health Research.) This class is open to the public and is being offered by NCATS’ Education Branch in partnership with the Foundation for Advanced Education in the Sciences (FAES). Registration for the course is open. Please note that if you do not already have an FAES account, you will be required to create one before you can complete the course … Continue reading

JAMA Publishes Practice-Changing Findings of JHACH-Led, NIH-Funded, Randomized Clinical Trial


The Journal of the American Medical Association (JAMA) has just published the practice-changing findings of the NIH-funded multinational Kids-DOTT randomized clinical trial.   View the Publication   Article Courtesy of Mike Stephenson | Johns Hopkins All Children’s Hospital This landmark trial, led by Neil Goldenberg, M.D., Ph.D., associate dean for research, and the Clinical Coordinating Center team in the Johns Hopkins All Children’s Institute for Clinical and Translational Research, involved an Investigators Group that Goldenberg assembled over a decade ago, focused on the emerging pediatric challenge of venous thromboembolism (VTE—also known as “blood clots,” including deep vein thrombosis (DVT) and pulmonary embolism (PE)). … Continue reading

Free NIH Course in Neurotherapeutics Discovery and Development March 28-31, 2022


NIH Course in Neurotherapeutics Discovery and Development for Academic Scientists March 29-31 2022 Applications are due January 24, 2022   This 4 day short course focuses on the drug discovery and development of novel neurotherapeutics.  It’s a mix of didactic lectures, workshops, round robins, and one-on-one academic/pharma mentorship.  Only 35-40 students are accepted each year.  It has been very popular, with excellent reviews from past participants, and taught by a mix of Pharma industry and academic drug discovery professionals.  If selected, all expenses are covered including food, lodging and travel. Graduate student/post doc/fellow/faculty are encouraged to attend. For more information … Continue reading

Congratulations Barbara Bates-Hopkins, Winner of a 2021 Martin Luther King Jr. Award for Community Service


MLK Jr. Community Service Awards Ceremony January 14, 2022 | Noon – 1:00 pm Register   This award recognizes meaningful voluntary community service by faculty, staff and students of The Johns Hopkins University and the Johns Hopkins Health System Meet the winners: From Johns Hopkins University: 1.    Barbara Bates-Hopkins 2.    Aleesha Eccleston (Johns Hopkins Summer Jobs Program MLK Winner) 3.    Phoebe Evans Letocha 4.    Nanette Smith 5.    Michael Preston Barbara Bates-Hopkins is a native Baltimorean, who grew up in East Baltimore and today, serves as a community engagement coordinator for Johns Hopkins University. As a C-RAC … Continue reading

Funding Opportunity: Johns Hopkins and Kaiser Permanente Research Collaboration Committee Pilot Grant


The Johns Hopkins and Kaiser Permanente Research Collaboration Committee (RCC) is sponsoring joint research applications for 2022.   Applications are due by 5pm Eastern Time on January 31, 2022   Please read the request for applications for submission information and contact Nancy Ortiz at Nancy.N.Ortiz@kp.org with any issues uploading your application. The RCC will grant funding for proposals which best represent initial research that leverages the unique capabilities of Kaiser Permanente and Johns Hopkins as learning health systems. Research proposals should align with both organizations’ strategic priorities: Innovations in using Epic® (KP HealthConnect) to improve health care Demonstrating and improving … Continue reading

New Johns Hopkins Medicine Website Dedicated to Current Clinical Research Policies & News


Johns Hopkins Master’s Students Develop Ideas to Improve Hospital Safety


Article courtesy of Emily Myrick/ The HUB Since its inception in 2015, the interdisciplinary project through the Institute for Clinical and Translational Research has prompted meaningful changes in hospital protocol Last month, 16 teams of Johns Hopkins engineering students presented doctors, nurses, and administrative staff at Johns Hopkins Hospital with recommendations, written reports, and prototypes designed to improve the safety and efficiency of hospital care, the conclusion of an eight-week project facilitated by the Institute for Clinical and Translational Research. This consulting project, which the Master of Science in Engineering Management program informally calls the “hospital project,” is part of Strategies for Innovation … Continue reading

Barbara Slusher, Co-leader of the Drug, Biologics, Vaccines and Devices Translational Research Community, Founds Startup Connected to Treating Prostate Cancer


  Article courtesy of Johns Hopkins Technology Ventures   Barbara Slusher, Ph.D., M.A.S., director of Johns Hopkins Drug Discovery, and co-leader of the ICTR Drug, Biologics, Vaccines and Devices Translational Research Community recently sold to Bayer AG her startup that developed a shielding agent for a patient’s normal tissue that can be used during a cutting edge, targeted radiotherapeutic treatment for prostate cancer. “To me,” she says, “the science story here is the value of keeping your eyes open, because if you do, failures can turn into successes.” That’s because Slusher is not a prostate cancer expert — she is a … Continue reading

New Data Protection Attestation Incorporated into eIRB System


New Data Protection Attestation streamlines paperwork associated with sharing limited data sets for research among JHU researchers.   The Data Protection Attestation available here outlines expectations for the protection of patient data and serves as a data use agreement to enable the sharing of limited data sets among JHU researchers, (both those in and outside of the JHM covered entity).   As of 8/26/2021, when study team members “agree to participate” for any study in eIRB and when a PI submits a new application or further study action, researchers agree to the terms of the Data Protection Attestation.   This … Continue reading

Mark Sulkowski Named Senior Associate Dean for Clinical Trials and the Founding Director of the Office of Clinical Trials


Mark Sulkowski, MD, Director of the COVID-19 Clinical Research Center named senior associate dean for clinical trials and the founding director of the Office of Clinical Trials at the Johns Hopkins University School of Medicine.   In his new role, Dr. Sulkowski will oversee activities related to clinical trials, focusing on commercial clinical trials. In addition, he will help develop an integrated approach to trial-related training, support and oversight. He will join the team of Gail Daumit, the new vice dean for clinical investigation, and with her will collaborate closely with Daniel Ford, director of the Institute for Clinical and … Continue reading

Right Program Could Turn Immune Cells into Cancer Killers


Cancer-fighting T cells from patients whose cancers responded to immunotherapy and from those whose tumors did not respond showed marked differences A tumor-specific T cell engages with a tumor cell. Bystander T cells do not engage with the tumor. Credit: PNAS Dec. 10, 2002, Copyright (2002) National Academy of Sciences, U.S.A.   Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different “program” that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at … Continue reading